These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 24528374

  • 1. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
    Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubiński J, Cybulski C.
    Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
    [Abstract] [Full Text] [Related]

  • 2. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
    Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska Ł, Haus O, Janiszewska H, Niepsuj S, Góźdź S, Zaremba L, Posmyk M, Płuzańska M, Kilar E, Czudowska D, Waśko B, Miturski R, Kowalczyk JR, Urbański K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Tołoczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojć B, Mierzejewski M, Narod SA, Lubiński J.
    Int J Cancer; 2004 Jul 10; 110(5):683-6. PubMed ID: 15146557
    [Abstract] [Full Text] [Related]

  • 3. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B.
    Hered Cancer Clin Pract; 2006 Aug 15; 4(3):142-52. PubMed ID: 20223018
    [Abstract] [Full Text] [Related]

  • 4. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
    Uglanitsa N, Oszurek O, Uglanitsa K, Savonievich E, Lubiński J, Cybulski C, Debniak T, Narod SA, Gronwald J.
    Clin Genet; 2010 Oct 15; 78(4):377-80. PubMed ID: 20507347
    [Abstract] [Full Text] [Related]

  • 5. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.
    Oncol Rep; 2008 Jan 15; 19(1):263-8. PubMed ID: 18097605
    [Abstract] [Full Text] [Related]

  • 6. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Jan 15; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Sokolenko AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, Iyevleva AG, Aleksakhina SN, Romanko AA, Bessonov AA, Gorodnova TV, Anisimova EI, Savonevich EL, Bizin IV, Stepanov IA, Krivorotko PV, Berlev IV, Belyaev AM, Togo AV, Imyanitov EN.
    Breast Cancer Res Treat; 2020 Nov 15; 184(1):229-235. PubMed ID: 32776218
    [Abstract] [Full Text] [Related]

  • 9. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
    Grzybowska E, Siemińska M, Zientek H, Kalinowska E, Michalska J, Utracka-Hutka B, Rogozińska-Szczepka J, Kaźmierczak-Maciejewska M.
    Acta Biochim Pol; 2002 Nov 15; 49(2):351-6. PubMed ID: 12362976
    [Abstract] [Full Text] [Related]

  • 10. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E.
    Hum Mutat; 2000 May 15; 15(5):480-1. PubMed ID: 10790213
    [Abstract] [Full Text] [Related]

  • 11. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E, Zientek H, Jasinska A, Rusin M, Kozlowski P, Sobczak K, Sikorska A, Kwiatkowska E, Gorniak L, Kalinowska E, Utracka-Hutka B, Wloch J, Chmielik E, Krzyzosiak WJ.
    Hum Mutat; 2000 Dec 15; 16(6):482-90. PubMed ID: 11102977
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
    Ławniczak M, Jakubowska A, Białek A, Lubiński J, Jaworska-Bieniek K, Kaczmarek K, Starzyńska T.
    Hered Cancer Clin Pract; 2016 Dec 15; 14():3. PubMed ID: 26779294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA.
    Hum Mutat; 2002 Nov 15; 20(5):352-7. PubMed ID: 12402332
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.
    Gynecol Oncol; 2001 Nov 15; 83(2):383-7. PubMed ID: 11606101
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.